Bandaru S. Reddy - Concepedia

Author

Bandaru S. Reddy

Also Known As

B S Reddy, B. Shanthi Reddy, BANDARU S. REDDY, Bandaru Reddy, Bandaru S Reddy, Bandaru S. REDDY, Bandaru S. Reddy, Reddy, Bandaru S.

249

Publications

19.8K

Citations

H-Index

104

Concepts

All Affiliations

Institute for Cancer Prevention Rutgers, The State University of New Jersey Dana (United States)National Institutes of Health University of Notre Dame

About

Bandaru S. Reddy is an author at Institute for Cancer Prevention specializing in medicine, pathology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	112	12.6K
2	Public Health	28	35	3.2K
3	Health Sciences	13	14	1K
4	Natural Sciences	4	4	552
5	Allergy	2	2	228

Bandaru S. Reddy

157

Publications

17.4K

Citations

H-Index

Page 1

	Year	Citations
Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Chinthalapally V. Rao, Abraham Rivenson, Barbara Simi, PubMed InflammationColon CarcinogenesisChemoprevention StrategyDietary CurcuminMedicine	1995	676
Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis Tin Oo Khor, Mou‐Tuan Huang, Ki Han Kwon, Cancer Research	2006	518
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Bandaru S. Reddy, Yoshinobu Hirose, Ronald A. Lubet, PubMed OncologyColon TumorsCox-2 InhibitorColon CarcinogenesisMedicine	2000	462
Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Bandaru S. Reddy, Koichi Watanabe, John H. Weisburger, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1977	439
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Bandaru S. Reddy, Chinthalapally V. Rao, Karen Seibert PubMed Acf DevelopmentAnti-inflammatoryColon CarcinogenesisCrypt MultiplicityPotential Chemopreventive Properties	1996	422
Metabolic epidemiology of colon cancer:Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps Bandaru S. Reddy, Ernst L. Wynder Cancer	1977	411
Large-Bowel Carcinogenesis: Fecal Constituents of Populations With Diverse Incidence Rates of Colon Cancer2 Bandaru S. Reddy, Ernest L. Wynder JNCI Journal of the National Cancer Institute NutritionDietary ExposureGastroenterologyPathologyNeutral Sterol Excretion	1973	410
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Chinthalapally V. Rao, Abraham Rivenson, Barbara Simi, PubMed Anti-inflammatoryOncologyColon CarcinogenesisChemoprevention StrategyGastrointestinal Pharmacology	1995	404
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats Bandaru S. Reddy, Chinthalapally V. Rao, Abraham Rivenson, Carcinogenesis Chemoprevention StrategyPathologyPharmacotherapyColonic MucosalOxidative Stress	1993	346
Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Bandaru S. Reddy, Hiroko Maruyama, Gary Kelloff PubMed OncologyColon CarcinogenesisColon Tumor MultiplicityChemoprevention StrategyGastrointestinal Pharmacology	1987	303

Page 1